Harold W. Davis

2.1k total citations
41 papers, 1.7k citations indexed

About

Harold W. Davis is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Harold W. Davis has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Physiology and 9 papers in Immunology. Recurrent topics in Harold W. Davis's work include Protein Kinase Regulation and GTPase Signaling (8 papers), Regulation of Appetite and Obesity (8 papers) and Phagocytosis and Immune Regulation (6 papers). Harold W. Davis is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (8 papers), Regulation of Appetite and Obesity (8 papers) and Phagocytosis and Immune Regulation (6 papers). Harold W. Davis collaborates with scholars based in United States, Germany and Australia. Harold W. Davis's co-authors include Joe G. N. Garcia, Carolyn E. Patterson, Ying Zhao, Jenny Tong, David A. D’Alessio, Matthias H. Tschöp, Martin Bidlingmaier, Ronald L. Prigeon, Steven E. Kahn and David E. Cummings and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Harold W. Davis

40 papers receiving 1.6k citations

Peers

Harold W. Davis
Anjali K. Nath United States
Vicky L. Funanage United States
Jean M. Camden United States
J. Daniel Frantz United States
Ya Su United States
Veronica Prpić United States
Anjali K. Nath United States
Harold W. Davis
Citations per year, relative to Harold W. Davis Harold W. Davis (= 1×) peers Anjali K. Nath

Countries citing papers authored by Harold W. Davis

Since Specialization
Citations

This map shows the geographic impact of Harold W. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold W. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold W. Davis more than expected).

Fields of papers citing papers by Harold W. Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold W. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold W. Davis. The network helps show where Harold W. Davis may publish in the future.

Co-authorship network of co-authors of Harold W. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Harold W. Davis. A scholar is included among the top collaborators of Harold W. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold W. Davis. Harold W. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallabhapurapu, Subrahmanya, Harold W. Davis, Eric P. Smith, et al.. (2025). TLR2-Bound Cancer-Secreted Hsp70 Induces MerTK-Mediated Immunosuppression and Tumorigenesis in Solid Tumors. Cancers. 17(3). 450–450. 2 indexed citations
2.
Davis, Harold W., et al.. (2024). Clinical characteristics and outcomes of adrenal hemorrhage. Surgery. 176(1). 76–81. 1 indexed citations
4.
Sun, Ying, Benjamin Liou, Zhengtao Chu, et al.. (2020). Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease. EBioMedicine. 55. 102735–102735. 26 indexed citations
5.
Davis, Harold W., Zhengtao Chu, Subrahmanya Vallabhapurapu, et al.. (2020). Enhanced Efficacy of Combination of Gemcitabine and Phosphatidylserine-Targeted Nanovesicles against Pancreatic Cancer. Molecular Therapy. 28(8). 1876–1886. 16 indexed citations
6.
Tong, Jenny, Harold W. Davis, Amalia Gastaldelli, & David A. D’Alessio. (2016). Ghrelin Impairs Prandial Glucose Tolerance and Insulin Secretion in Healthy Humans Despite Increasing GLP-1. The Journal of Clinical Endocrinology & Metabolism. 101(6). 2405–2414. 37 indexed citations
7.
Davis, Harold W., et al.. (2016). Detection of cancer cells using SapC-DOPS nanovesicles. Molecular Cancer. 15(1). 33–33. 17 indexed citations
8.
Tong, Jenny, Ronald L. Prigeon, Harold W. Davis, et al.. (2013). Physiologic Concentrations of Exogenously Infused Ghrelin Reduces Insulin Secretion Without Affecting Insulin Sensitivity in Healthy Humans. The Journal of Clinical Endocrinology & Metabolism. 98(6). 2536–2543. 41 indexed citations
9.
Tong, Jenny, Pascaline Aimé, Paul T. Pfluger, et al.. (2011). Ghrelin Enhances Olfactory Sensitivity and Exploratory Sniffing in Rodents and Humans. Journal of Neuroscience. 31(15). 5841–5846. 129 indexed citations
10.
Davis, Harold W., et al.. (2005). Paclitaxel Impairs Endothelial Cell Adhesion But Not Cytokine-Induced Cellular Adhesion Molecule Expression. Annals of Vascular Surgery. 19(3). 398–406. 11 indexed citations
11.
Edwards, John D., et al.. (2004). The role of the cytoskeleton in cellular adhesion molecule expression in tumor necrosis factor‐stimulated endothelial cells. Journal of Cellular Biochemistry. 91(5). 926–937. 30 indexed citations
12.
Mammen, Joshua M.V., Jaekyung C. Song, James J. Yoo, et al.. (2004). Differential subcellular targeting of PKC-ε in response to pharmacological or ischemic stimuli in intestinal epithelia. American Journal of Physiology-Gastrointestinal and Liver Physiology. 288(1). G135–G142. 3 indexed citations
13.
Zhao, Ying & Harold W. Davis. (2000). Endotoxin causes phosphorylation of MARCKS in pulmonary vascular endothelial cells. Journal of Cellular Biochemistry. 79(3). 496–505. 7 indexed citations
14.
Neltner, Bonnie, Ying Zhao, David B. Sacks, & Harold W. Davis. (2000). Thrombin-induced phosphorylation of MARCKS does not alter its interactions with calmodulin or actin. Cellular Signalling. 12(2). 71–79. 10 indexed citations
15.
Zhao, Ying & Harold W. Davis. (1998). Hydrogen peroxide-induced cytoskeletal rearrangement in cultured pulmonary endothelial cells. Journal of Cellular Physiology. 174(3). 370–379. 96 indexed citations
16.
Davis, Harold W.. (1997). Phosphorylation of Calmodulin by Myosin Light Chain Kinase Is Altered by Exchange or Duplication of EF-Hand Pairs. Biochemical and Biophysical Research Communications. 236(3). 702–705. 2 indexed citations
17.
Davis, Harold W., Dan L. Crimmins, Richard S. Thoma, & Joe G. N. Garcia. (1996). Phosphorylation of Calmodulin in the First Calcium-Binding Pocket by Myosin Light Chain Kinase. Archives of Biochemistry and Biophysics. 332(1). 101–109. 16 indexed citations
18.
Zhao, Ying & Harold W. Davis. (1996). Thrombin-induced phosphorylation of the myristoylated alanine-rich C kinase substrate (MARCKS) protein in bovine pulmonary artery endothelial cells. Journal of Cellular Physiology. 169(2). 350–357. 14 indexed citations
19.
Garcia, Joe G. N., Harold W. Davis, & Carolyn E. Patterson. (1995). Regulation of endothelial cell gap formation and barrier dysfunction: Role of myosin light chain phosphorylation. Journal of Cellular Physiology. 163(3). 510–522. 472 indexed citations
20.
Sacks, David B., et al.. (1992). Casein kinase II-catalysed phosphorylation of calmodulin is altered by amino acid deletions in the central helix of calmodulin. Biochemical and Biophysical Research Communications. 188(2). 754–759. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026